Saturday, May 17, 2025
10.6 C
London

Primis Financial Hit with 10-Q Filing Delay



Primis Financial Delays Filing of Quarterly Report, Cites Need for Additional Time

In a notification of late filing, Primis Financial Corp. (FRST) has announced that it will be delaying the filing of its Form 10-Q (Quarter Report) for the financial period ending March 31, 2025. According to the company, the delay is primarily due to the need for additional time to complete necessary documentation, disclosures, and analyses.

The news was reported by TipRanks, a financial data and analytics firm, which provides insights and analysis on stocks and investment opportunities. As stated by TipRanks, “The company anticipates filing the report within five calendar days following the original due date.” There are no expected significant changes in financial results for this period, and forward-looking statements caution against undue reliance due to potential risks and uncertainties.

In a statement, Primis Financial’s Chief Financial Officer, Matthew A. Switzer, signed the notification, indicating that the company is actively working to ensure compliance with regulatory requirements. This delay in filing may raise concerns among investors, but according to TipRanks, the most recent analyst rating on FRST stock is a Buy with a $14.00 price target.

TipRanks’ AI Analyst, Spark, has provided an analysis of FRST stock, rating it as Neutral. As reported by TipRanks, “FRST is a Neutral” with a challenging financial landscape, including declining profitability and mixed technical indicators. However, the strategic growth initiatives outlined in the earnings call provide a positive outlook, and the valuation remains a concern due to the negative P/E ratio.

In terms of stock performance, TipRanks reports that Primis Financial has an average trading volume of 103,968, a technical sentiment signal of Sell, and a current market cap of $230.4M. For a thorough assessment of FRST stock, investors can visit TipRanks’ Stock Analysis page.

Overall, while Primis Financial’s delay in filing its quarterly report may raise concerns, the company’s strategic growth initiatives and forward-looking statements suggest a positive outlook. As TipRanks notes, “the stock shows potential for improvement with strategic execution, but current risks weigh heavily.” Investors can stay informed about FRST stock and other investment opportunities by visiting TipRanks, a trusted source for financial data and analysis.

The delay in filing the quarterly report is a significant development for Primis Financial, and investors will be closely watching the company’s progress in the coming days. According to TipRanks, the company is working to ensure compliance, and the notification of late filing has been signed by Chief Financial Officer Matthew A. Switzer.

In conclusion, Primis Financial’s delay in filing its quarterly report is a notable development, but the company’s strategic growth initiatives and forward-looking statements suggest a positive outlook. As reported by TipRanks, investors can stay informed about FRST stock and other investment opportunities by visiting their website.

This news article has been sourced from TipRanks, a leading provider of financial data and analytics. For more information on Primis Financial and FRST stock, please visit .



Source link

Hot this week

Doctor Who’s Future Hangs in the Balance Post-Disney

Doctor Who's Future Secured: Show to Continue Beyond...

Doctor Who Secures BBC One Renewal Amid Disney+ Uncertainty

Doctor Who Fans Receive Reassurance Over Future of...

Doctor Who Scripts Secure, Despite Disney Funding Woes

Doctor Who to Continue Beyond Current Series, Sources...

Primis Financial Corp. Files SEC 10-Q Report: Key Insights

Primis Financial Corp. Reports Strong Q1 2025 Results,...

Chelsea Shift Focus to ‘Top Target’ Over Garnacho Summer Deal

Chelsea Shift Focus Away from Alejandro Garnacho to...

Topics

Doctor Who’s Future Hangs in the Balance Post-Disney

Doctor Who's Future Secured: Show to Continue Beyond...

Doctor Who Secures BBC One Renewal Amid Disney+ Uncertainty

Doctor Who Fans Receive Reassurance Over Future of...

Doctor Who Scripts Secure, Despite Disney Funding Woes

Doctor Who to Continue Beyond Current Series, Sources...

Primis Financial Corp. Files SEC 10-Q Report: Key Insights

Primis Financial Corp. Reports Strong Q1 2025 Results,...

Chelsea Shift Focus to ‘Top Target’ Over Garnacho Summer Deal

Chelsea Shift Focus Away from Alejandro Garnacho to...

Chelsea Drops Pursuit of Man United Winger

Chelsea FC will host fierce rivals Manchester United...

Chelsea Favors Gittens Over Garnacho in Transfer Pursuit

Chelsea FC have reportedly cooled their interest in...

Aubrey O’Day Steps Forward: Singer to Testify as Diddy’s Witness

Aubrey O'Day to Testify Against Sean "Diddy" Combs...

Related Articles

Popular Categories